# A Study of Talazoparib in Patients With Advanced Solid Tumors

> **NCT03070548** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Talazoparib

## Key facts

- **NCT ID:** NCT03070548
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070548, "A Study of Talazoparib in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03070548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*